Could shedding assets spell a breakthrough for troubled GE?
Share Now on:
General Electric today announced the sale of its biopharmaceutical business for more than $21 billion dollars. The buyer is Danaher Corporation, which happens to have been previously run by GE chief executive Larry Kulp, who served as chief executive at Danaher between 2001 and 2015. The move is part of an ongoing restructuring aimed at paying down GE’s massive debt load and focusing on core industries the company is invested in, such as aviation and power.
Click the audio player above to hear the full story.
As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.
Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.
Donate today — in any amount — to become a Marketplace Investor. Now more than ever, your commitment makes a difference.